Menu

Blog

Archive for the ‘biotech/medical’ category: Page 2344

Aug 9, 2017

Researchers develop technology to make aged cells younger

Posted by in categories: biotech/medical, life extension

Aging. We all face it. Nobody’s immune and we’ve long tried to reverse it, stop it or just even slow it down. While advances have been made, true age-reversal at a cellular level remains difficult to achieve. By taking a different approach, however, researchers at Houston Methodist made a surprising discovery leading to the development of technology with the ability to rejuvenate human cells. And that couldn’t be more important for the small population of children who are aging too quickly — children with progeria.

John P. Cooke, M.D., Ph.D., department chair of cardiovascular sciences at Houston Methodist Research Institute, and his colleagues, describe their findings in a Research Letter titled “Telomerase mRNA Reverses Senescence in Progeria Cells,” appearing online July 31 and in print Aug. 8 in the Journal of the American College of Cardiology, a leading medical journal in the field of cardiovascular disease.

Cooke studied cells from children with , a rare condition marked by rapid aging that usually robs them of the chance to live beyond their early teens. They focused on progeria, because the condition tells them a lot about aging in general that’s ultimately relevant to all of us.

Continue reading “Researchers develop technology to make aged cells younger” »

Aug 8, 2017

‘Alexa, I’m ready to walk’: Robotics company using Amazon’s AI to help control exoskeleton

Posted by in categories: biotech/medical, cyborgs, robotics/AI

It’s one thing to be wowed by Amazon’s Alexa and her ability to turn off Katy Perry, or turn on the lights. But what if the voice-activated artificial intelligence could help control a robotic device designed to help people walk?

That’s the hope of Bionik Laboratories, which announced Tuesday that it has integrated Alexa into its ARKE lower body exoskeleton. The product is in clinical development, and the future goal is for individuals who have suffered a spinal cord injury or are otherwise severely impaired in their lower body to gain mobility such as standing and walking.

Read more

Aug 8, 2017

Halting Pulmonary Fibrosis

Posted by in categories: biotech/medical, life extension

Cellular senescence is widely considered by academia to be one of the causes of aging and one that leads to a number of age-related diseases. There has been a high level of interest in recent years in cellular senescence and approaches that seek to remove senescent cells as a route to delaying or even preventing age-related diseases.

Today we have a new study where researchers focus on pulmonary fibrosis and the role of cellular senescence.

Read more

Aug 8, 2017

LEAF President Keith Comito asks whether the CRISPR gene editing system will help cure aging in the near term

Posted by in categories: bioengineering, biotech/medical, life extension

Dr. Oliver Medvedik, Dr. Aubrey de Grey, and Dr. Alexandra Stolzing discuss.

Read more

Aug 7, 2017

Veritas Genetics Scoops Up an AI Company to Sort Out Its DNA

Posted by in categories: biotech/medical, genetics, life extension, robotics/AI

News from Veritas and remember Veritas are offering a whole genome sequence as one of the rewards in our AgeMeter campaign at Lifespan.io:

https://www.lifespan.io/campaigns/agemeter-biomarker-scan/#reward_12

“On August 3, sequencing company Veritas Genetics bought one of the most influential: seven-year old Curoverse. Veritas thinks AI will help interpret the genetic risk of certain diseases and scour the ever-growing databases of genomic, medical, and scientific research.”

Continue reading “Veritas Genetics Scoops Up an AI Company to Sort Out Its DNA” »

Aug 7, 2017

The Future of Politics Will Focus on Transhumanism

Posted by in categories: biotech/medical, cyborgs, genetics, geopolitics, life extension, robotics/AI, transhumanism

As one of the most visible 2016 presidential candidates—and now as a leading 2018 contender for Governor in California—Zoltan Istvan has been the “Science Candidate,” traveling around America to discuss the issues of transhumanism and radical longevity that are transforming humanity. Soon the issues of AI, genetic editing, designer babies, bionic organs, automation, and neural prosthetics will challenge and dominate political discourse. America must embrace radical science with bold polices.

Read more

Aug 7, 2017

If we can build a brain, what is the future of “I”?

Posted by in categories: biological, biotech/medical, ethics, futurism, health, transhumanism

The study of consciousness and what makes us individuals is a topic filled with complexities. From a neuroscience perspective, consciousness is derived from a self-model as a unitary structure that shapes our perceptions, decisions and feelings. There is a tendency to jump to the conclusion with this model that mankind is being defined as self-absorbed and only being in it for ourselves in this life. Although that may be partially true, this definition of consciousness doesn’t necessarily address the role of morals and how that is shaped into our being. In the latest addition to The Galactic Public Archives, Dr. Ken Hayworth tackles the philosophical impact that technologies have on our lives.

Follow us on social media:
Twitter / Facebook / Instagram

Aug 7, 2017

Elena Milova of LEAF asks whether senolytic therapies for senescent cells could have an adverse effect on the number of functional stem cells in the body

Posted by in categories: biotech/medical, life extension

Dr. Alexandra Stolzing and Dr. Aubrey de Grey discuss.

Read more

Aug 7, 2017

CRISPR star Jennifer Doudna calls for public debate on embryo editing

Posted by in categories: biotech/medical, genetics

Jennifer Doudna reflects on what she sees as achievements and misuses of CRISPR genetic editing method.

Read more

Aug 5, 2017

This FDA Approved Drug Could Permanently Repair Brain Damage in Stroke Victims

Posted by in categories: biotech/medical, neuroscience

  • Using a drug already approved for clinical trials, researchers were able to reduce brain damage and boost the growth of new brain cells in mice suffering from strokes.
  • The research offers new hope to those dealing with the aftermath of strokes, which are the fifth leading cause of death in the United States.

Researchers from the University of Manchester have developed a new treatment that could limit the damage caused by strokes and also promote repair in the affected area of the brain. What’s more, the drug they’re using has already been clinically approved.

Read more